Experimental Lung Transplantation Related With HIF-1, VEGF, ROS. Assessment of HIF-1alpha, VEGF, and Reactive Oxygen Species After Competitive Blockade of Chetomin for Lung Transplantation in Rats
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Chetomin treatment significantly reduced reactive oxygen species (ROS) and hypoxia-inducible factor-1 alpha (HIF-1alpha) levels in lung transplantation. This suggests chetomin may improve graft survival by mitigating oxidative stress and inflammation.
Area Of Science
- Transplantation immunology
- Molecular biology
- Biochemistry
Background
- Primary graft failure impacts 15-30% of lung transplantations.
- While lung preservation has improved, transcription factor regulation remains understudied.
Purpose Of The Study
- To investigate the effect of chetomin on reactive oxygen species (ROS) production and vascular endothelial growth factor (VEGF) expression in lung transplantation.
- To evaluate the role of hypoxia-inducible factor-1 alpha (HIF-1alpha) in lung preservation.
Main Methods
- Experimental lung transplantation study with 5 groups, including controls and treatments with DMSO or chetomin.
- Measurement of ROS, mRNA, and protein levels of HIF-1alpha and EG-VEGF.
Main Results
- Both DMSO and chetomin groups showed significantly lower ROS levels.
- The chetomin group exhibited the lowest HIF-1alpha levels compared to the immediate reperfusion (I-R) group.
Conclusions
- Chetomin administration to both donor and receptor significantly reduces HIF-1alpha, VEGF, and ROS levels.
- Chetomin shows potential in improving lung graft outcomes by modulating key molecular pathways.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.